New LaunchJun 26, 2026, 04:08 PM
Meihua International Medical Launches New SaaS Business
AI Summary
Meihua International Medical Technologies Co., Ltd. announced the launch of a new Software-as-a-Service (SaaS) business initiative through its U.S. subsidiary, Meihua Future Manufacturing Limited. This strategic pivot, initiated on a trial basis in July 2025, aims to develop and sell medical registration SaaS systems in North America, Hong Kong, and Southeast Asia. The new business contributed approximately 2.6% to the company's total revenue for fiscal year 2025 and has already secured $16.125 million in signed contracts, with plans for an extraordinary general meeting in August 2026 to align with this transition.
Key Highlights
- Launched a new Software-as-a-Service (SaaS) business on a trial basis since July 2025.
- SaaS business generated approximately 2.6% of total revenue for fiscal year ended December 31, 2025.
- Plans to develop and sell medical registration SaaS systems across North America, Hong Kong, and Southeast Asia.
- North America accounts for over 54% of the global medical SaaS market.
- Southeast Asia's digital health market shows a 24% CAGR.
- Secured cumulative signed contracts totaling $16.125 million for the new SaaS business segment.
- Intends to hold an extraordinary general meeting in August 2026 for strategic transition to SaaS.
Price Impact